Denis Naughten (Roscommon-South Leitrim, Independent)
Link to this: Individually | In context | Oireachtas source

913. To ask the Minister for Health if he will outline the number of adverse reactions and severe adverse reactions to each vaccine administered under the State funded vaccination programme in each of the past five years; the number of cases settled with the State claims agency and the number pending for each vaccine; and if he will make a statement on the matter. [27296/13]

James Reilly (Dublin North, Fine Gael)
Link to this: Individually | In context | Oireachtas source

Responsibility for recording adverse events rests with the licensing authority for medicines. The competent authority for licensing and safety of all medicines licensed in Ireland, including vaccines is the Irish Medicines Board (IMB). The IMB has advised that the information requested by the Deputy is being collated and will be forwarded to him as soon as it is available.

Since 2010 the State Claims Agency has had statutory responsibility to manage the public liability claims made against the Health Service Executive. I am advised by the SCA that there have been two cases relating to vaccines. One claim involving MMR vaccine which is currently on appeal to the Supreme Court following a hearing in the High Court in July 2011 where the plaintiff's case was dismissed. The second case is ongoing and relates to celevapan vaccine.

Denis Naughten (Roscommon-South Leitrim, Independent)
Link to this: Individually | In context | Oireachtas source

914. To ask the Minister for Health the position regarding the establishment of a compensation fund for the parents of vaccine damaged children; when a decision will be made on the implementation of the recommendations of this report; and if he will make a statement on the matter. [27297/13]

James Reilly (Dublin North, Fine Gael)
Link to this: Individually | In context | Oireachtas source

My Department is currently examining the recommendations of the Vaccine Damage Steering Group. However, this issue is complex and needs to be considered in the wider context of how best to address the long term health and social needs of people who may have experienced adverse outcomes from other health services.